<DOC>
	<DOCNO>NCT01890629</DOCNO>
	<brief_summary>To compare efficacy safety initial combination therapy Gemigliptin versus Sitagliptin Glimepiride Metformin Glucose Variability ( MAGE , Glucose SD ) Patients With Type 2 Diabetes Mellitus .</brief_summary>
	<brief_title>Effects Gemigliptin Versus Sitagliptin Glimepiride With Metformin Glucose Variability ( MAGE , Glucose SD ) Patients With Type 2 DM ( STABLE Study )</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Glimepiride</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>Patients Type 2 Diabetes Mellitus adult age ≥ 20 age ≤ 70 year old Patients take anti diabetes drug 8 week prior screen visit HbA1c ≥ 7.5 % All patient give write informed consent Patients applicable one follow 3 category 1 . Patients surgically induced infertility 2 . Postmenopause woman ≥45 year age 2 year last menstruation 3 . Fertile premenopause woman male patient consent use two contraceptive method least 14 day final administration investigational product avoid get pregnant Patients Type 1 Diabetes , Patients Diabetic Ketoacidosis Diabetic Coma well Precoma Patients Gestational Diabetes Mellitus Secondary Diabetes Patients NYHA Class III , IV Congestive Heart Failure Treatmentrequiring Arrhythmia Patients Thyroid Dysfunction whose TSH normal range , require medication therapy Patients pituitary insufficiency hypoadrenalism Patients whose BMI le 20 Kg/m2 exceeds 40 Kg/m2 Patients whose Total Bilirubin level 1.5 time high upper limit normal range ALT/AST &gt; 2.5 time high upper limit normal range Patients currently take strong CYP3A4 inducer Patients currently take Warfarin , Dicoumar Digoxin Patients currently take medication within 4 week Visit 1 ( screen ) likely significant effect glycemic control require take medication Patients take antiobesity drug within 12 week prior Visit 1 ( screen ) Subject treat Insulin GLP1 analogue within 6 month Visit 1 ( screen ) Patients participate clinical study past 3 month Visit 1 ( screen ) Any patient investigator considers inadequate study</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>diabetes mellitus</keyword>
</DOC>